Injectable medicine for type 2 diabetes with metformin
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational injection called SYH2069 that may help lower blood sugar in people with type 2 diabetes who are already on metformin. It aims to see if the injection is safe and effective when added to diet, exercise, and metformin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need a diagnosis of type 2 diabetes for at least 12 weeks (about 3 months).
- Your body mass index (BMI) must be between 22 and 40. (You can ask your doctor to check this.)
- You must be taking metformin and following a diet/exercise plan stably for the last 8 weeks.
- Your average blood sugar (HbA1c) must be between 7.5% and 10.5% at the screening visit.
- You cannot have certain serious health conditions like recent heart attack, stroke, or pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
Hear when a new T2DM (Type 2 Diabetes Mellitus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.